Application of Traditional Chinese Medicine in the different pathological stages of ischemic stroke: Target immune cells
Ageing Research Reviews · 2025
DOI: 10.1016/j.arr.2025.102866 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2025. Verfasst von Yulu Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, PR China. Electronic address: yulu.wang@nju…. Hauptthemen laut MEDLINE: Ischemic Stroke, Medicine, Chinese Traditional, Drugs, Chinese Herbal, Microglia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 292 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Natural Science Research of Jiangsu Higher Education Institutions of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Immune cells play a pivotal role in the complex pathophysiology of ischemic stroke (IS), with their functions dynamically shifting throughout the disease's progression. Throughout the different pathological stages of IS, various immune cells, such as microglia, T cells, neutrophils, NK cells, and mononuclear/macrophages, contribute uniquely to the disease's trajectory. Although thrombolytic therapy remains the standard treatment for IS, its efficacy is limited by a narrow therapeutic window, underscoring the need for alternative or adjunctive therapeutic strategies. Increasingly, the therapeutic potential of Traditional Chinese Medicine (TCM) has gained recognition for its beneficial effects across multiple phases of IS. Notably, TCM interventions have been shown to attenuate early inflammatory responses and neural injury by targeting immune cells, particularly microglia. Furthermore, during the recovery phase, TCM may promote white matter repair and functional recovery through the regulation of neuroimmune interactions. This review offers a comprehensive analysis of the dynamic roles and signaling pathways of immune cells in IS, and further investigates the mechanistic basis of TCM's immunomodulatory effects. While considerable progress has been made, significant challenges remain in fully elucidating the underlying mechanisms of TCM and in optimizing its integration into current IS treatment frameworks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, PR China. Electronic address: yulu.wang@njucm.edu.cn.
- School of Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, PR China. Electronic address: wyuanee@njucm.edu.cn.
- School of Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, PR China. Electronic address: liulele@njucm.edu.cn.
- Department of Neurology, Nanjing Hospital of Chinese Medicine Afffliated to Nanjing University of Chinese Medicine, Nanjing 210022, PR China. Electronic address: huizhen68@sohu.com.
- Department of Neurology, Nanjing Hospital of Chinese Medicine Afffliated to Nanjing University of Chinese Medicine, Nanjing 210022, PR China. Electronic address: wangsulei99@163.com.
- Department of Neurology, Nanjing Hospital of Chinese Medicine Afffliated to Nanjing University of Chinese Medicine, Nanjing 210022, PR China. Electronic address: zhuguoxue0122@163.com.
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Natural Science Research of Jiangsu Higher Education Institutions of China
- Key Project of Science and Technology Development of Nanjing Medicine
- Nanjing University of Chinese Medicine
- Jiangsu Commission of Health
Zitieren
APA
Wang, Y., Wang, Y., Liu, L., Hui, Z., Wang, S., Zhu, G., Wang, L., Zhang, Z., & Hu, Y. (2025). Application of Traditional Chinese Medicine in the different pathological stages of ischemic stroke: Target immune cells. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2025.102866
Vancouver
Wang Y, Wang Y, Liu L, Hui Z, Wang S, Zhu G, et al. Application of Traditional Chinese Medicine in the different pathological stages of ischemic stroke: Target immune cells. Ageing Research Reviews. 2025. doi:10.1016/j.arr.2025.102866
BibTeX
@article{Wang2025,
author = {Wang, Yulu and Wang, Yuanyi and Liu, Lele and Hui, Zhen and Wang, Sulei and Zhu, Guoxue and Wang, Lining and Zhang, Zhennian and Hu, Yue},
title = {Application of Traditional Chinese Medicine in the different pathological stages of ischemic stroke: Target immune cells},
journal = {Ageing Research Reviews},
year = {2025},
doi = {10.1016/j.arr.2025.102866}
}
EUVIMED